A groundbreaking study from the University of Arizona suggests that pyrvinium pamoate, a drug originally designed for pinworm ...

When Katie Doble was diagnosed with a rare cancer, she was given 16 months to live. Clinical trials gave her a second chance.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

Subscribe!